Comment · Sun, January 10, 2016
Deoxygedunin is a small-molecule TrkB agonist with improved potency and duration relative to 7,8-DHF
What they were answering
[deleted] · 1 points
[deleted]
u/MisterYouAreSoDumb
Oral bioavailability is huge in the pharma world. Mainstream people really won't use any other ROA. Hell, even I wouldn't till I started Ceretropic, and got talked into it. Haha